Infertility Services

We understand the physical, emotional and financial stress caused by seeking treatment for infertility. We offer the latest treatments and compassionate care to optimize your chances of creating your family! Our practitioner will perform a completed fertility evaluation and offer services including ovulation induction and intra-uterine insemination (IUI). If you require surgery or in-vitro fertilization (IVF) we will refer you to a highly-qualified specialist.

Intrauterine Insemination

Intrauterine insemination (IUI) is a fertility treatment that places sperm inside the uterus to promote fertilization. The goal is to allow more sperm to reach the fallopian tubes in order increase the chances of fertilization. IUIs at MCFNP are performed in either natural, clomiphene citrate, or gonadotropin stimulated cycles.

Intrauterine Insemination is performed when ovulation is approaching. Sperm is gathered from your partner before the procedure. (Advance Fertility Center at Odessa Regional Medical Center’s laboratory?) prepares the sperm, and they are committed to making sure the highest quality of sperm is gathered from the sample provided. A small catheter is used to transfer the sperm into the uterus, and the IUI is relatively painless.


Artificial Insemination

Artificial insemination using donor sperm is most commonly performed when couples learn that the man is sterile. It is also performed when single women would like to conceive. Donor sperm used at MCFNP are gathered from approved cryopreserved donor sperm banks that are FDA approved, as well as follow strict, mandated infectious disease screening.


Polycystic Ovary Syndrome is a syndrome that affects about 5% to 10% or women between the ages of 18 and 44. PCOS has many unfortunate symptoms that include infertility, menstrual problems, hair loss on the scalp, hair increase on the face and body, and acne. If untreated, PCOS can lead to Type 2 diabetes and heart disease.

If diagnosed with PCOS, we will work with you to create a plan to help overcome PCOS and infertility. We will also help try to prevent the long term problems associated with PCOS. Minimizing risk is important to us, so we will recommend the best medication used to treat PCOS. This includes clomiphene citrate, Metformin, and if these do not work, gonadotropin therapy. We understand that dealing with PCOS is tough battle, but we at MCFNP are committed to helping you win the fight.


If women are experiencing trouble ovulating due to PCOS, clomiphene citrate is the best option used combatting this. Clomid is taken orally, and is usually well tolerated by women, but side effects include nausea, mood changes, depression, and vaginal dryness.


Gonadotropins are two hormones, luteinizing hormone (LH) and follicle stimulating hormone (FSH), and these are usually produced by the pituitary gland. These hormones stimulate the ovaries to help produce a follicle, which contains the egg.

Diagnostic Testing

The beginning of the process starts with an evaluation. Your medical history will be reviewed along with any exams you have previously had. We will also decide if any additional testing will need to take place. Each patient is different, and is going through different challenges. Dealing with infertility can feel overwhelming, but we will give you ample opportunity to ask questions or bring up any concerns you have.  At MCFNP we will work with you to determine the best plan of action, and tailor a plan that will give you the greatest chance to conceive.


Unlike men who produce sperm throughout their lifetimes, woman are born with their lifetime supply of eggs. After a woman passes the usual childbearing years, it becomes much harder to conceive. Women under 30 have the greatest chance to conceive, while women over 40 may have difficulties conceiving. As soon as a woman no longer has any eggs, menopause begins. Usually occurring when a woman is in her early 50s.  The average age for menopause to occur in American women is 51.

Although finding out exactly how many eggs a woman has left cannot be done, a number of tests can be performed to help estimate how many eggs are left in the ovaries.



This test determines the follicle stimulating hormone levels, and is taken during the third day of the menstrual cycle. Usually healthy levels of FSH for women are nine and under. Anything over that means that it will be harder for the woman to conceive.


This tests the female pituitary hormone levels in females. It makes use of the medication Clomid, and helps accurately determine if a woman has a decreased ovarian reserve.


The Anti-Mullerian Hormone is a hormone produced by oocytes. As ovarian function declines, so does AMH. The acceptable AMH value is still being debated, but values greater than 1.0 or 1.2 are usually accepted as normal. This test differs from day 3 testing because AMH levels do not change throughout the month, meaning that the test can be taken at any time of the month.


This is a transvaginal ultrasound taken during the start of a woman’s menstrual cycle where the number of resting or unstimulated ovarian follicles are noted. If a woman has a low Resting Follicle Count, she may not be responding very well to fertility medication.


Some women may have irregular or absent ovulation, reflected by irregular or absent menses. Additionally, some women experience clinical androgen excess as evidenced by hirsutism (male pattern facial hair) or acne.

Here at MCFNP, we may request blood studies to ascertain the origin of these reproductive endocrine disorders. Furthermore, referral to a Reproductive Endocrinologist may be indicated for the evaluation and treatment with rare and complex reproductive endocrine diseases.


Male infertility is the source of a couple’s inability to conceive about 20 – 40% of the time. If a severe male factor is present, IVF-ICSI (intracytoplasmic sperm injection) may be suggested as a primary treatment and couple would be referred to Reproductive Endocrinology specialist. For couples with a mild male factor, intrauterine inseminations may be suggested.


Sonohysterogram/Saline Infusion Sonogram (SIS). This office based procedure, commonly performed at MCFNP, allows us to view the uterine cavity. During the transvaginal ultrasound, sterile saline is inserted through the cervix and into the uterus through a narrow tube. This well tolerated procedure allows the provider to see the walls of the uterus and evaluate for the presence of intrauterine growths such as polyps or fibroids. Additionally, a SIS is an excellent screening study to determine the location of fibroids and their relationship to the uterine cavity.


This radiological procedure has been a mainstay of infertility physicians for decades. It is regarded as the principle screening study to help determine if the fallopian tubes are patent (open) or occluded. Additionally, an HSG can help determine if the uterine cavity has any filling defects, including fibroids or polyps. Radio-opaque dye is inserted past the cervix and into the uterine cavity while X-ray images are obtained. HSGs are not always accurate, but are considered a very good screening study.